Cardiovascular Diseases Clinical Trial
Official title:
Compliance, Viability and Effectiveness of Home Based Cardiac Rehabilitation: a Randomised Trial
The proposal of this study is to verify if it is feasible and effective to offer a home based cardiac rehabilitation program, that includes the components of health education and physical exercises mostly unsupervised and oriented by telephone and to compare the treatment adherence, the effects in the functional capacity, and the control of coronary risk factors in relation to the traditional cardiac rehabilitation offered mostly supervised and center based.
This study will be developed with patients with coronary disease submitted to angioplasty or
myocardial revascularization surgery, provided they are considered of low and moderate risk
for the practice of physical exercise of moderate intensity, according to the risk
stratification proposed by the American Association of Cardiovascular and Pulmonary
Rehabilitation. Volunteers will be recruited at the outpatient at the University Hospital's
Cardiac Rehabilitation Centre. The study will be made in conformity with the CONSORT
guidelines for non-pharmacological interventions. After being invited to the study, the
volunteer whose accept the participation and sign the consent form will be randomized into
two different groups: Traditional cardiac rehabilitation (mostly supervised) and
Telerehabilitation (mostly unsupervised). The randomization will be made through the
www.randomization.com website in blocks of four volunteers each. A blind researcher will
evaluate participants before and after test, and will fulfill the database.
Intervention The parameters for the exercise prescription will be the same for both groups.
Exercise sessions will be constituted of 5-10 minutes of warm up, 40 minutes of aerobic
activity with heart rate between 60 and 80% of the heart rate reserve, and 5-10 minutes of
cool down. The educational sessions will be given to both groups in six meetings with 40
minutes each, and items regarding the control of risk factors and treatment of cardiovascular
diseases will be approached. After the period of 12 weeks of intervention all participants
will be stimulated to continue to practice physical exercises at home or at the community,
and they will be invited to a re-evaluation after three months.
Groups:
Traditional cardiac rehabilitation as control group (CentreRehab) The CentreRehab group will
be made supervised exercises and health educational activities, personally at cardiac
rehabilitation centre. This intervention will last 12 weeks, with a total of 60 sessions: 24
supervised and 36 at home (to complete five exercise's sessions for week). The participants
of this group will be oriented to fulfill a training diary with information regarding the
frequency of the exercises, the presence of symptoms, and the use of the scale of perceived
exertion during exercises at home.
Home-based cardiac rehabilitation (HomeRehab) The participants of the HomeRehab group will
make the exercise mostly at home. There will be weekly phone calls, in person educational
sessions, and monthly meetings to check the execution of the previous stage, solve doubts, or
identify the presence of symptoms or undesirable effects. This intervention will have the
duration of 12 weeks, with a total of 60 sessions: 2 supervised and 58 at home (to complete
five exercise's sessions for week).
In the first week, all individuals of HomeRehab group will receive a training regarding the
use of the monitoring equipment. A heart rate monitor with the heart rate zone individually
calculated will be given to the participant at the first session of the face-to-face training
to monitoring exercises at home. Furthermore, all participants of this group will use a step
counter (pedometer) to stimulate the execution of the exercises as well as training diary to
be fulfilled with information regarding the frequency of the exercises, the presence of
symptoms during the exercise, the perceived exertion, and the number of daily steps. The
monthly meetings will take place to the educational activity, and to verify if the exercises
and fulfilment of the training diary are correct as well as to clarify any kind of the
participant's doubts.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|